Bilateral Clareon IOLs in Cataract Patients: TruPlus vs Monofocal
Official title: A Prospective, Randomized, Subject- and Examiner-Masked, Multicenter Study Comparing Bilateral Clareon TruPlus and Bilateral Clareon Monofocal Intraocular Lens Implantation (Spherical and Toric) in Cataract Subjects
Run by Berkeley Eye Center · NCT07693205 · Data updated 2026-11-12
This study tests whether implanting Clareon TruPlus bilateral IOLs works as well as Clareon monofocal bilateral IOLs in adults with cataracts.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 22 Years and up |
| Sex | All |
| Enrollment | 180 (estimated) |
| Sponsor | Berkeley Eye Center Academic / other |
| Locations | 1 site (Sugar Land, Texas) |
| Status | Recruiting |
| Started | June 12, 2026 |
| Main results expected | July 2027 |
| Study ends | July 2027 |
| Registry record updated | July 21, 2026 |
| Trial ID | NCT07693205 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 22 years or older with visually significant cataracts, planning bilateral surgery, with postoperative expected visual acuity of 20/25 or better in each eye, and suitable corneal astigmatism correction options.
✕Probably not a fit
Patients whose eyes do not achieve adequate visual correction or who experience adverse events related to the IOLs may not benefit from the study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective, randomized, bilateral implantation study in adults with visually significant cataracts. Participants receive either Clareon TruPlus or Clareon monofocal IOLs in both eyes, with spherical and toric models allowed based on preoperative planning. Subjects and postoperative examiners are masked to which IOL was implanted, while surgeons know the assignment. The primary endpoint is assessed at 3 months after surgery, and the study follows a parallel-group design at multiple centers. Outcomes focus on vision-related measures and safety of the two IOL options.
Why it matters
Potential benefit: If successful, the TruPlus IOL could provide comparable or superior vision quality with similar safety to monofocal IOLs, potentially expanding options for patients undergoing cataract surgery.
How similar studies have gone: Previous randomized bilateral cataract studies have used similar masked, parallel designs; the approach is established but this specific IOL comparison is novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Adult cataract patients aged ≥22 years scheduled for cataract surgery in both eyes due to visually significant cataracts. 2. Ability to understand and sign an IRB/ethics committee-approved informed consent form. 3. Willingness and ability to attend all scheduled study visits as required by the protocol and complete all study testing procedures. 4. Postoperative potential visual acuity of 20/25 or better in each eye, as determined by the investigator. 5. Preoperative corneal astigmatism that can be corrected with a T3-T5 toric IOL, or with a spherical IOL plus LRIs/Aks, with either resulting in a predicted postoperative astigmatism \<0.50 D. 6. IOL power and, if toric, cylinder availability within labeled ranges for the assigned IOL family. 7. Ability to understand and complete study questionnaires. Exclusion Criteria: 1. Women who are pregnant, planning to become pregnant during the study period, or breastfeeding (by verbal confirmation). 2. Ocular conditions that could confound study results, including moderate-to-severe corneal pathology, irregular astigmatism, moderate-to-severe dry eye/ocular surface disease not optimized, preexisting retinal degenerative disease (e.g., age-related macular degeneration), diabetic retinopathy, or other clinically significant retinal pathology. 3. Any form of confirmed glaucomatous optic neuropathy or other optic nerve disease expected to affect visual function outcomes. 4. History of amblyopia, monofixation syndrome, or other binocular vision disorder with poor stereopsis that could confound binocular testing. 5. Prior ocular surgery (including corneal refractive surgery) in either eye. 6. Zonular laxity/dehiscence, pseudoexfoliation with clinically significant zonulopathy, nystagmus, or strabismus that could compromise uncomplicated surgery or reliable visual testing. 7. Participation in another clinical study (interventional) that could interfere with study results. 8. Planned monovision/mini-monovision or desire for monovision targeting. 9. Systemic conditions that may affect healing or visual outcomes (e.g., uncontrolled diabetes mellitus, certain autoimmune disorders) per investigator judgment. 10. Psychiatric or cognitive disorders that may impair the ability to comply with study procedures or provide reliable self-assessments. 11. Any active ocular infection or inflammation.
Where it's running
-
Berkeley Eye Center - Sugar Land
Sugar Land, Texas, United States Recruiting
Study contacts
- Study coordinator: Tetiana Huff
- Email: tetiana.huff@berkeleyeye.com
- Phone: 713-620-7640
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Rotational Stability of the Acunex Vario Toric
This study tests whether the Acunex Vario toric extended-depth-of-focus intraocular lens stays stable in rotation and effectively reduces astigmatism for people undergoing cataract surgery.
-
Anterior segment anatomy assessment with swept-source OCT in eye surgery patients
This study tests whether swept-source OCT can detail front-eye anatomy in patients undergoing anterior segment eye surgery.
-
MiLOOP-assisted cataract surgery for dense cataracts
In people with dense cataracts, this study tests whether using the miLOOP device during cataract surgery can protect corneal cells and reduce ultrasound energy, compared with standard surgery.
-
Visual adaptation and quality of life after different IOL implantation options
This study follows adults who have cataracts and receive bilateral multifocal or mixed IOLs to see how their vision and daily life improve over 6 months.
-
Corneal Biomechanics and Surgical Astigmatism after Cataract Surgery in Pseudoexfoliation
This study tests how the cornea's biomechanical properties before cataract surgery relate to the amount of blinking surgically induced astigmatism, comparing people with pseudoexfoliation to those without.
-
Neuroplastic pain education and guided breathing during awake cataract surgery
This trial tests whether the STEIN Protocol, a non-drug approach with pain education, guided imagery, and paced breathing, helps adults having cataract surgery require less pain medicine and feel less anxious.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.